Dimitris Papoutsakis oversees operations, program and portfolio management at Tango Therapeutics. Dimitris brings over 16 years of drug development experience across several therapeutic areas. He joined Tango Therapeutics from Novartis Oncology, where he was senior director in oncology business development and licensing. There, he oversaw alliances with biotech and pharmaceutical companies. Dimitris has also held roles at the Novartis Institute for Biomedical Research in chemical development, pharmaceutical development, technical project management and oncology program management, where he was the Cambridge site head of the group.
Dimitris obtained his Bachelor of Science in chemistry from the University of Crete in Greece, his doctorate in chemistry from Michigan State University, and he completed a postdoctoral fellowship at Massachusetts Institute of Technology.